162 related articles for article (PubMed ID: 17704644)
1. The ubiquitin E3 ligase Cbl-b in T cells tolerance and tumor immunity.
Loeser S; Penninger JM
Cell Cycle; 2007 Oct; 6(20):2478-85. PubMed ID: 17704644
[TBL] [Abstract][Full Text] [Related]
2. Regulation of peripheral T cell tolerance by the E3 ubiquitin ligase Cbl-b.
Loeser S; Penninger JM
Semin Immunol; 2007 Jun; 19(3):206-14. PubMed ID: 17391982
[TBL] [Abstract][Full Text] [Related]
3. Spontaneous tumor rejection by cbl-b-deficient CD8+ T cells.
Loeser S; Loser K; Bijker MS; Rangachari M; van der Burg SH; Wada T; Beissert S; Melief CJ; Penninger JM
J Exp Med; 2007 Apr; 204(4):879-91. PubMed ID: 17403934
[TBL] [Abstract][Full Text] [Related]
4. Essential role of E3 ubiquitin ligase activity in Cbl-b-regulated T cell functions.
Paolino M; Thien CB; Gruber T; Hinterleitner R; Baier G; Langdon WY; Penninger JM
J Immunol; 2011 Feb; 186(4):2138-47. PubMed ID: 21248250
[TBL] [Abstract][Full Text] [Related]
5. Regulation of immune responses by E3 ubiquitin ligase Cbl-b.
Tang R; Langdon WY; Zhang J
Cell Immunol; 2019 Jun; 340():103878. PubMed ID: 30442330
[TBL] [Abstract][Full Text] [Related]
6. E3 ubiquitin ligase Cbl-b in innate and adaptive immunity.
Liu Q; Zhou H; Langdon WY; Zhang J
Cell Cycle; 2014; 13(12):1875-84. PubMed ID: 24875217
[TBL] [Abstract][Full Text] [Related]
7. Cbl-b and itch: key regulators of peripheral T-cell tolerance.
Venuprasad K
Cancer Res; 2010 Apr; 70(8):3009-12. PubMed ID: 20395198
[TBL] [Abstract][Full Text] [Related]
8. Negative regulation of CD40-mediated B cell responses by E3 ubiquitin ligase Casitas-B-lineage lymphoma protein-B.
Qiao G; Lei M; Li Z; Sun Y; Minto A; Fu YX; Ying H; Quigg RJ; Zhang J
J Immunol; 2007 Oct; 179(7):4473-9. PubMed ID: 17878343
[TBL] [Abstract][Full Text] [Related]
9. PKC-theta modulates the strength of T cell responses by targeting Cbl-b for ubiquitination and degradation.
Gruber T; Hermann-Kleiter N; Hinterleitner R; Fresser F; Schneider R; Gastl G; Penninger JM; Baier G
Sci Signal; 2009 Jun; 2(76):ra30. PubMed ID: 19549985
[TBL] [Abstract][Full Text] [Related]
10. Cutting edge: deficiency in the E3 ubiquitin ligase Cbl-b results in a multifunctional defect in T cell TGF-beta sensitivity in vitro and in vivo.
Wohlfert EA; Gorelik L; Mittler R; Flavell RA; Clark RB
J Immunol; 2006 Feb; 176(3):1316-20. PubMed ID: 16424156
[TBL] [Abstract][Full Text] [Related]
11. Cbl- and Nedd4-family ubiquitin ligases: balancing tolerance and immunity.
Gay DL; Ramón H; Oliver PM
Immunol Res; 2008; 42(1-3):51-64. PubMed ID: 18827983
[TBL] [Abstract][Full Text] [Related]
12. Casitas B lineage lymphoma b is a key regulator of peripheral tolerance in systemic lupus erythematosus.
Gómez-Martín D; Ibarra-Sánchez M; Romo-Tena J; Cruz-Ruíz J; Esparza-López J; Galindo-Campos M; Díaz-Zamudio M; Alcocer-Varela J
Arthritis Rheum; 2013 Apr; 65(4):1032-42. PubMed ID: 23280105
[TBL] [Abstract][Full Text] [Related]
13. Lys63-polyubiquitination by the E3 ligase casitas B-lineage lymphoma-b (Cbl-b) modulates peripheral regulatory T cell tolerance in patients with systemic lupus erythematosus.
Romo-Tena J; Rajme-López S; Aparicio-Vera L; Alcocer-Varela J; Gómez-Martín D
Clin Exp Immunol; 2018 Jan; 191(1):42-49. PubMed ID: 28940360
[TBL] [Abstract][Full Text] [Related]
14. Control of the B cell-intrinsic tolerance programs by ubiquitin ligases Cbl and Cbl-b.
Kitaura Y; Jang IK; Wang Y; Han YC; Inazu T; Cadera EJ; Schlissel M; Hardy RR; Gu H
Immunity; 2007 May; 26(5):567-78. PubMed ID: 17493844
[TBL] [Abstract][Full Text] [Related]
15. E3 ubiquitin ligase Casitas B lineage lymphoma-b and its potential therapeutic implications for immunotherapy.
Jafari D; Mousavi MJ; Keshavarz Shahbaz S; Jafarzadeh L; Tahmasebi S; Spoor J; Esmaeilzadeh A
Clin Exp Immunol; 2021 Apr; 204(1):14-31. PubMed ID: 33306199
[TBL] [Abstract][Full Text] [Related]
16. Cbl-b in T-cell activation.
Paolino M; Penninger JM
Semin Immunopathol; 2010 Jun; 32(2):137-48. PubMed ID: 20458601
[TBL] [Abstract][Full Text] [Related]
17. Releasing the brake: targeting Cbl-b to enhance lymphocyte effector functions.
Wallner S; Gruber T; Baier G; Wolf D
Clin Dev Immunol; 2012; 2012():692639. PubMed ID: 22550535
[TBL] [Abstract][Full Text] [Related]
18. Cbl-b gene silencing in splenic T lymphocytes as a therapeutic strategy to target the prostate cancer RM-1 cell tumors in immune competent mice.
Shi ZD; Li XF; Hao L; Zhao Y; Wang YX; Dong BZ; Chen WH; Zhang ZG; Wang YM; Fu Q; Han CH; Li S
Eur Rev Med Pharmacol Sci; 2014; 18(24):3819-30. PubMed ID: 25555872
[TBL] [Abstract][Full Text] [Related]
19. Differential control of CD28-regulated in vivo immunity by the E3 ligase Cbl-b.
Krawczyk CM; Jones RG; Atfield A; Bachmaier K; Arya S; Odermatt B; Ohashi PS; Penninger JM
J Immunol; 2005 Feb; 174(3):1472-8. PubMed ID: 15661906
[TBL] [Abstract][Full Text] [Related]
20. The E3 ligase Cbl-b and TAM receptors regulate cancer metastasis via natural killer cells.
Paolino M; Choidas A; Wallner S; Pranjic B; Uribesalgo I; Loeser S; Jamieson AM; Langdon WY; Ikeda F; Fededa JP; Cronin SJ; Nitsch R; Schultz-Fademrecht C; Eickhoff J; Menninger S; Unger A; Torka R; Gruber T; Hinterleitner R; Baier G; Wolf D; Ullrich A; Klebl BM; Penninger JM
Nature; 2014 Mar; 507(7493):508-12. PubMed ID: 24553136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]